Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (351-360 of 598) with videos related to

Pageof 60
Sort By:
Haematologica|March 28, 2008
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID miceBrunangelo Falini, Maria Paola Martelli, Cristina Mecucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AMLBing Z Carter, Po Yee Mak, Suresh Satpati, et al.
Patterns (New York, N.Y.)|October 25, 2021
Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasmsNanditha Mallesh, Max Zhao, Lisa Meintker, et al.
Leukemia|May 28, 2024
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patientsSandra Huber, Natalie Wossidlo, Torsten Haferlach, et al.
Blood Advances|March 20, 2026
IDH1 and IDH2 mutated myeloid neoplasms: mutational pattern, clonal hierarchy and the role in AML transformationSandra Huber, Flora Goessweiner, Wencke Walter, et al.
American Journal of Hematology|November 5, 2019
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromesVikas Madan, Jia Li, Siqin Zhou, et al.
Haematologica|June 27, 2012
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSusanne Schnittger, Ulrike Bacher, Tamara Alpermann, et al.
Haematologica|October 17, 2015
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaTamara Alpermann, Susanne Schnittger, Christiane Eder, et al.
Leukemia|December 19, 2025
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencingMarietta Truger, Manja Meggendorfer, Wencke Walter, et al.
Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.
Pageof 60

Showing results (351-360 of 598) with videos related to

Sort By:
Pageof 60
Haematologica|March 28, 2008
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID miceBrunangelo Falini, Maria Paola Martelli, Cristina Mecucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AMLBing Z Carter, Po Yee Mak, Suresh Satpati, et al.
Patterns (New York, N.Y.)|October 25, 2021
Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasmsNanditha Mallesh, Max Zhao, Lisa Meintker, et al.
Leukemia|May 28, 2024
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patientsSandra Huber, Natalie Wossidlo, Torsten Haferlach, et al.
Blood Advances|March 20, 2026
IDH1 and IDH2 mutated myeloid neoplasms: mutational pattern, clonal hierarchy and the role in AML transformationSandra Huber, Flora Goessweiner, Wencke Walter, et al.
American Journal of Hematology|November 5, 2019
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromesVikas Madan, Jia Li, Siqin Zhou, et al.
Haematologica|June 27, 2012
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSusanne Schnittger, Ulrike Bacher, Tamara Alpermann, et al.
Haematologica|October 17, 2015
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaTamara Alpermann, Susanne Schnittger, Christiane Eder, et al.
Leukemia|December 19, 2025
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencingMarietta Truger, Manja Meggendorfer, Wencke Walter, et al.
Blood|October 29, 2015
Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemiaMichaela Wagner, Madlen Oelsner, Andrew Moore, et al.
Pageof 60